Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[PET/CT and thyroid carcinoma].

E Banti1, L Rampin, D Rubello

  • 1Unità PET, Servizio di Medicina Nucleare, Ospedale S. Maria della Misericordia, Istituto Oncologico Veneto, IRCCS, Rovigo, Italy.

Minerva Chirurgica
|October 20, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Technetium-99m-labeled lapachol as an imaging probe for breast tumor identification.

Revista espanola de medicina nuclear e imagen molecular·2019
Same author

The role of <sup>18</sup>F-FDG PET/CT imaging in the diagnosis of ovarian cancer.

Revista espanola de medicina nuclear e imagen molecular·2018
Same author

Additional value of hybrid SPECT/CT systems in neuroendocrine tumors, adrenal tumors, pheochromocytomas and paragangliomas.

Revista espanola de medicina nuclear e imagen molecular·2016
Same author

Hybrid-fusion SPECT/CT systems in parathyroid adenoma: Technological improvements and added clinical diagnostic value.

Revista espanola de medicina nuclear e imagen molecular·2016
Same author

Update on PET/CT colonography in the diagnosis of colorectal cancer.

Revista espanola de medicina nuclear e imagen molecular·2016
Same author

Effects of the Antihypertensive Fixed-Dose Combinations on an Early Marker of Hypertensive Cardiac Damage in Subjects at Low Cardiovascular Risk.

American journal of hypertension·2016
Same journal

Unexpected evolution of COVID-19 in a heart transplant patient with multimorbidity recently submitted to thoracic surgery.

Minerva chirurgica·2020
Same journal

Ongoing clinical trials on axillary management.

Minerva chirurgica·2020
Same journal

Axillary management after neoadjuvant treatment.

Minerva chirurgica·2020
Same journal

Axillary observation alone versus sentinel node biopsy: past, present and future perspectives.

Minerva chirurgica·2020
Same journal

Patient flow for the management of ostomy patients.

Minerva chirurgica·2020
Same journal

The management of "fragile" and suspected COVID-19 surgical patients during pandemic: an Italian single-center experience.

Minerva chirurgica·2020
See all related articles

Positron emission tomography (PET) aids in diagnosing differentiated thyroid cancer, especially iodine-negative tumors resistant to standard treatments. PET and PET-CT also show promise in identifying suspected thyroid nodules.

Area of Science:

  • Nuclear Medicine
  • Oncology
  • Radiology

Background:

  • Differentiated thyroid cancer (DTC) diagnosis often relies on iodine scintigraphy.
  • Some DTCs become iodine-negative, particularly in elderly patients, exhibiting increased aggressiveness.
  • External radiotherapy and chemotherapy have limited efficacy, making surgery the primary treatment.

Purpose of the Study:

  • To review the indications and clinical outcomes of Positron Emission Tomography (PET) in differentiated thyroid cancer.
  • To explore the role of PET and PET-CT in diagnosing iodine-negative tumors and suspected thyroid nodules.

Main Methods:

  • Review of existing literature on PET and PET-CT applications in differentiated thyroid cancer.
  • Discussion of clinical results and diagnostic value.

Related Experiment Videos

Main Results:

  • PET and PET-CT are increasingly important for early diagnosis of small tumoral deposits in DTC.
  • These imaging techniques show potential in the differential diagnosis of suspected thyroid nodules.
  • PET is valuable for iodine-negative tumors, which are more aggressive and common in the elderly.

Conclusions:

  • PET and PET-CT offer significant advantages in managing differentiated thyroid cancer, especially for iodine-negative cases.
  • These advanced imaging modalities improve early detection and differential diagnosis of thyroid lesions.
  • Further research into PET's role in DTC management is warranted.